Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genome- |
RCV001563763 | SCV001786782 | uncertain significance | Gaucher disease type I | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001563764 | SCV001786783 | uncertain significance | Gaucher disease type II | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002495899 | SCV002790226 | uncertain significance | Lewy body dementia; Gaucher disease type I; Gaucher disease type II; Gaucher disease type III; Gaucher disease perinatal lethal; Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome; Parkinson disease, late-onset | 2021-12-07 | criteria provided, single submitter | clinical testing | |
Gene |
RCV003128785 | SCV003805864 | uncertain significance | not provided | 2022-08-16 | criteria provided, single submitter | clinical testing | Reported previously in control sample cohorts for both Parkinson disease and Gaucher disease and not seen in the affected patients (Wolf et al., 2018; Ruskey et al., 2019); In silico analysis supports that this missense variant does not alter protein structure/function; Also known as p.(T410M); This variant is associated with the following publications: (PMID: 29842932, 29100779) |